←Hematology & Oncology
Anemia & transfusion
📚
🔴

Anemia & transfusion

MCV + reticulocytes in 2 minutes, iron deficiency done right, and restrictive transfusion triggers.

anemiatransfusioniron deficiencyhemolysisMINT
🗓️ Reviewed 2026-11-18 · ⏱️ 3 min read · 📖 2023 AABB RBC transfusion guideline · MINT trial (2023) · AGA 2020 iron deficiency guideline
🧠 Pathophysiology in 60 seconds🔎 Diagnosis💊 Management⚠️ Pitfalls🎓 Board corner📚 References
⚡ Bottom line — first hour
  • Transfuse at Hb <7 g/dL for most hospitalized adults (AABB 2023). <8 for cardiac/orthopedic surgery or existing CVD.
  • Acute MI with anemia: a more liberal strategy (Hb <10) may be reasonable (MINT trend toward benefit).
  • One unit at a time, then reassess. Each unit raises Hb ~1 g/dL.
  • Workup = MCV + reticulocyte count → then targeted labs. Send iron studies before transfusing if possible.
  • Iron deficiency = ferritin <30 (or <100 with inflammation, CKD, HF) → find the source (GI workup in men and postmenopausal women).

🧠 Pathophysiology in 60 seconds

⌄
  • Anemia = too little production (low retics) or too much loss/destruction (high retics).
  • O₂ delivery = cardiac output × Hb × SaO₂. Healthy hearts compensate by raising output; ischemic hearts cannot → why CAD patients may need a higher threshold.
  • Hb drops slowly in chronic anemia → patients tolerate very low values; acute bleeds look worse at the same Hb.

🔎 Diagnosis

⌄
MCV Low retics (production) High retics (loss/destruction)
Low (<80) Iron deficiency, thalassemia, anemia of inflammation (some), sideroblastic, lead —
Normal Anemia of inflammation/CKD, early iron deficiency, marrow failure, mixed Acute bleed, hemolysis
High (>100) B12/folate, alcohol, liver disease, hypothyroid, MDS, drugs (MTX, hydroxyurea, AZT) Reticulocytosis itself raises MCV
Hemolysis labs Pattern
LDH ↑, indirect bilirubin ↑, haptoglobin ↓, retics ↑ Hemolysis
Smear: schistocytes MAHA → TTP/HUS/DIC/valve → urgent (PLASMIC score, ADAMTS13)
Smear: spherocytes + DAT positive Warm autoimmune hemolytic anemia
Bite cells, Heinz bodies G6PD (after drug, infection)
Iron studies Iron deficiency Inflammation
Ferritin Low (<30) Normal/high
TSAT Low (<20%) Low
TIBC High Low

💊 Management

⌄
Situation Threshold
Most hospitalized adults, ICU Hb <7
Cardiac surgery, orthopedic surgery, pre-existing CVD Hb <7.5–8
Acute MI Consider Hb <10 (MINT) — individualize
Active bleeding, hemorrhagic shock Clinical, not a number (massive transfusion protocol)
Oncology / hematologic malignancy Hb <7 (often 7–8)
  • Watch TACO (volume overload: give slowly, diurese between units in HF) and TRALI (hypoxemia within 6 h, non-cardiogenic).
  • Febrile non-hemolytic reaction → stop, rule out hemolysis.
  • Oral: ferrous sulfate 325 mg (65 mg elemental) once daily or every other day (better absorption, fewer GI effects).
  • IV iron if: intolerance, malabsorption (celiac, bariatric), CKD, HFrEF, ongoing loss, need for fast repletion (ferric carboxymaltose, ferric derisomaltose, iron sucrose).
  • Find the source: EGD + colonoscopy (men, postmenopausal women); celiac serology; menstrual history.
  • B12 deficiency: IM cyanocobalamin 1000 mcg daily ×1 week → weekly → monthly, or high-dose oral 1000–2000 mcg daily (works even without intrinsic factor).
  • Check B12 before giving folate (folate can mask B12 → neuro damage).
  • Methylmalonic acid ↑ = B12; homocysteine ↑ in both.

⚠️ Pitfalls

⌄
  • Transfusing "to 8" every morning in stable patients.
  • Iron studies drawn after transfusion (useless).
  • Ferritin 60 called "normal" in a CKD/HF patient.
  • Missing MAHA → TTP (look at the smear!).

🎓 Board corner

⌄
Stem Answer
Hb 6.8, ICU sepsis, stable Transfuse 1 unit
Hb 7.4, no symptoms, no CAD No transfusion
Microcytic, ferritin 8, man 60 y Iron deficiency → EGD + colonoscopy
Schistocytes, platelets 20 k, fever, AMS TTP → plasma exchange, caplacizumab
Hypoxemia 2 h after transfusion, no volume overload TRALI
Macrocytosis + neuropathy + vitiligo Pernicious anemia (B12)

📚 References

⌄
  • Carson JL, et al. AABB International Guidelines: Red Blood Cell Transfusion. JAMA. 2023;330:1892.
  • Carson JL, et al. MINT. NEJM. 2023;389:2446.
  • Ko CW, et al. AGA Guideline: GI evaluation of iron deficiency anemia. Gastroenterology. 2020;159:1085.
↩︎ Back to 🩸 Hematology & Oncology